News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Gilead Sciences, Inc. Announces Departure of Caroline Dorsa
January 21, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Caroline Dorsa has resigned from her position as Chief Financial Officer (CFO), a role she assumed in November 2007, to pursue another opportunity.
Twitter
LinkedIn
Facebook
Email
Print
People
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Business
Moderna Hits 2025 Revenue Goal as Operating Costs Fall Faster than Forecast
January 12, 2026
·
2 min read
·
Nick Paul Taylor
Layoff Tracker
Rampart Shuts Down, InflaRx cuts 30% of Staff
January 12, 2026
·
41 min read
·
BioSpace Editorial Staff
Gene editing
Startup Aurora Seeks To Replicate Baby KJ Success With $16M in Seed Money
January 12, 2026
·
2 min read
·
Tristan Manalac
IPO
Veradermics, Eikon Eye Public Market Debut as IPO Tap Opens
January 12, 2026
·
2 min read
·
Tristan Manalac